All In Biotech

Drug Trial Radar · NCT01484119

Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis

Multi-center, Double-blind, Double-dummy, Randomized, Placebo-controlled, Active-reference, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-129968 in Adolescent, Adult & Elderly Patients With Seasonal Allergic Rhinitis

Last checked: Nov 20, 2026Latest source record: Sep 28, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 630 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

630

Actual

Start

Dec 2011

Primary completion

Feb 2012

Study completion Mar 2012

Sponsor

Lead sponsor
Idorsia Pharmaceuticals Ltd.Industry
Sponsor type
Industry
First posted
Dec 2, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 12 years, up to 76 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will assess the efficacy and safety of ACT-129968 in adolescent, adult and elderly patients with seasonal allergic rhinitis, due to mountain cedar pollen.

Conditions

  • Seasonal Allergic Rhinitis

Interventions

  • ACT-129968Drug

    daily tablets

  • PlaceboDrug

    matching placebo tablets and capsules

  • CetirizineDrug

    daily capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The mean change in Daytime Nasal Symptom ScoreTime frame: baseline to end of treatment period (2 weeks)

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Investigative Site 7905

    Austin, Texas

  • Clinical Investigative Site 7907

    Kerrville, Texas

  • Clinical Investigative Site 7903

    New Braunfels, Texas

  • Clinical Investigative Site 7901

    San Antonio, Texas

  • Clinical Investigative Site 7902

    San Antonio, Texas

  • Clinical Investigative Site 7904

    San Antonio, Texas

  • Clinical Investigative Site 7906

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.